BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 18455967)

  • 1. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A; Gatta C; Festini F
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal septicaemia in patients with cystic fibrosis associated with totally implantable venous access device system.
    Gaber KA; Shenton L; Oades P; Colville A; Sheldon CD
    J Cyst Fibros; 2007 Sep; 6(5):317-9. PubMed ID: 17293171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
    Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
    G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.
    Royle TJ; Davies RE; Gannon MX
    Ann R Coll Surg Engl; 2008 Nov; 90(8):679-84. PubMed ID: 18990281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.
    Rodgers HC; Liddle K; Nixon SJ; Innes JA; Greening AP
    Eur Respir J; 1998 Jul; 12(1):217-20. PubMed ID: 9701441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cephalic vein access for implantable venous access devices. Technique and long-term follow-up].
    Conessa C; Talfer S; Herve S; Chollet O; Poncet JL
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(3):143-8. PubMed ID: 12577777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of an implantable venous access device in the groin using inferior epigastric vein.
    Singh SJ; Martin HC
    J Pediatr Surg; 2001 Apr; 36(4):579-81. PubMed ID: 11283881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilia in children with cystic fibrosis.
    Balfour-Lynn IM; Malbon K; Burman JF; Davidson SJ
    Pediatr Pulmonol; 2005 Apr; 39(4):306-10. PubMed ID: 15678507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on the insertion and management of central venous access devices in adults.
    Bishop L; Dougherty L; Bodenham A; Mansi J; Crowe P; Kibbler C; Shannon M; Treleaven J
    Int J Lab Hematol; 2007 Aug; 29(4):261-78. PubMed ID: 17617077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implantable vascular access devices for cystic fibrosis.
    A-Rahman A; Spencer D
    Cochrane Database Syst Rev; 2003; (3):CD004111. PubMed ID: 12918004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.